Skip to search formSkip to main contentSkip to account menu

fenclozic acid

Known as: 2-(4-chlorophenyl)-4--thiazoleacetic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Hepatic NADPH-cytochrome P450 oxidoreductase null (HRN™) mice exhibit no functional expression of hepatic cytochrome P450 (P450… 
2014
2014
Abstract 1. The distribution, metabolism, excretion and hepatic effects of fenclozic acid were investigated following a single… 
2014
2014
Fenclozic acid (Myalex) was developed by ICI pharmaceuticals in the 1960s for the treatment of rheumatoid arthritis and was a… 
1983
1983
In the rat [14C]fenclozic acid is not metabolized in the gut and passes into the portal blood unchanged. After intraduodenal… 
1981
1981
1. The metabolic fate of [14C]fenclozic acid (ICI 54450) in rat was determined after intraduodenal administration at different… 
1971
1971
The pharmacokinetic properties of the anti-inflammatory agent, fenclozic acid, have been established in the dog, calf, sheep, and… 
1969
1969
1 Fenclozic acid (2‐(4‐chlorophenyl)thiazol‐4‐ylacetic acid; I.C.I. 54, 450; “Myalex”) is one representative of a new class of… 
1969
1969
Inthepharmacological evaluation ofanewdrug muchistobegained byclose co-operation between clinical andindustrial research… 
1969
1969
Fenclozic acid (I.C.I. 54,450; 2-(p-chlorophenyl) thiazol-4-ylacetic acid; Myalex*) (Hepworth, Newbould, Platt, and Stacey, 1969…